CTR Center for Translational Research AB acquires A+ Science AB
CTR Center for Translational Research AB (CTR) has recently completed a strategic acquisition of A+ Science AB. As part of the agreement, all operations within A+ will be integrated into CTR’s wholly-owned subsidiary, CTC Clinical Trial Consultants AB (CTC).
The acquisition of A+ Science expands CTC’s portfolio of pharmacovigilance services and reinforces other operational activities. With this merger, CTC aims to expand its international presence and become an even stronger provider of CRO services. CTC’s extensive resources combined with A+ Science’s network and established collaborations with European CRO companies are expected to create synergies enabling more extensive clinical trials. The combined expertise of the companies also lays the groundwork for offering a comprehensive pharmacovigilance package that covers safety monitoring both during the clinical development program and post-approval.
In summary, the acquisition of A+ marks a significant milestone in CTC’s continued efforts to diversify its services and strengthen its position as an obvious and attractive player in the market.
“With the transfer of A+ Science to CTC, we will further develop our services for existing and new clients, and we are pleased to welcome the experienced staff of A+ to the CTR group”, says Karin Meyer, CEO of CTR.
“CTC sees great potential in this acquisition and we are excited about the new opportunities that arise from merging with A+”, says Anders Millerhovf, CEO of CTC.
“We look forward to merging with CTC, a Swedish company that shares A+ Science’s core values. Our previous collaboration with CTC has demonstrated their customer orientation and professionalism. A+ Science, with 26 years of experience and an extensive network in the Nordics and Europe, will enhance CTC. We have always offered cost-effective, tailored solutions, and the merger will boost our capacity to meet customer needs”, says Eva Fredriksson, CEO of A+.
Center for Translational Research AB (CTR) is a group of companies providing expert services and advice for product development in life sciences. CTR currently has seven subsidiaries supporting the pharmaceutical and medical technology industry: CTC Clinical Trial Consultants AB, Lablytica Life Science AB, RegSmart Life Science AB, Toxicology Knowledge Team Sweden AB, RegFile AB, Metasafe AB, and QAlliance AB. CTR is building a robust and sustainable translational research organization with the critical mass of experts and financial stability needed to support our national and international life science clients with improved treatments for patients. www.ctr-ab.se
CTC Clinical Trial Consultants AB (CTC) is a full-service CRO company focusing on clinical trials. Our mission is to facilitate clinical and translational research by offering our clients cost-effective advice, planning, conduct, and reporting of clinical trials. Our studies are conducted at CTC’s 6 own clinics located in Uppsala, Stockholm, Linköping, and Gothenburg. Our clinics work closely with our departments for clinical operations, biometrics, pharmacovigilance, as well as DMPK & Clinical Pharmacology to offer a truly full-service option to our clients. www.ctc-ab.se
A+ Science is a Swedish CRO (Contract Research Organization). The company offers services in clinical trials for pharmaceuticals (phase I – IV) and medical devices. For over 25 years, A+ Science has delivered clinical trial services for small, medium, and large pharmaceutical, medical technology, and biotech companies. The company also has broad competence and experience in Pharmacovigilance (PV) and offers services in this area for both clinical trials and marketed products. Through partnerships and close collaboration with an international network of other CROs, A+ Science can offer services in countries outside the Nordics. Over the years, A+ Science has been involved in clinical research that has made a positive difference in the lives of thousands of patients. www.a-plusscience.com